The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein Pathology

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases

Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351 · see citing works

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Molecular chaperones in protein folding and proteostasis

Hartl, F. U., Bracher, A., & Hayer-Hartl, M. K. (2011) · Nature · doi:10.1038/nature10317 · Cited by 3,525 · see citing works

Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563 · see citing works

Impairment of the Ubiquitin-Proteasome System by Protein Aggregation

Bence, N., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,192 · see citing works

Aggresomes: A Cellular Response to Misfolded Proteins

Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148 · see citing works

Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy

Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1× · see citing works

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · see citing works

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895 · see citing works

Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System

Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722 · see citing works

Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death

Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569 · see citing works

-Synuclein in Parkinson's Disease

Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446 · see citing works

Rapamycin: one drug, many effects

Li, J., Kim, S. G., & Blenis, J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.001 · Cited by 1,287 · see citing works

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

Bartels, T., Choi, J. G., & Selkoe, D. J. (2011) · Nature · doi:10.1038/nature10324 · Cited by 1,263 · cited 1× · see citing works

Chaperone Suppression of α-Synuclein Toxicity in a <i>Drosophila</i> Model for Parkinson's Disease

Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227 · see citing works

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208 · see citing works

A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci

Chang, D., Nalls, M. A., Hallgrímsdóttir, I. B., Hunkapiller, J., van der Brug, M., Cai, F., International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner, G. A., Ayalon, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3955 · Cited by 1,112 · see citing works

Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice

Luk, K. C., Kehm, V. M., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M. ‐. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112457 · Cited by 1,087 · see citing works

Microautophagy of Cytosolic Proteins by Late Endosomes

Sahu, R., Kaushik, S., Clement, C. C., Cannizzo, E. S., Scharf, B., Follenzi, A., Potolicchio, I., Nieves, E., Cuervo, A. M., & Santambrogio, L. (2011) · Developmental Cell · doi:10.1016/j.devcel.2010.12.003 · Cited by 902 · see citing works

Prion-like spreading of pathological α-synuclein in brain

Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai, T., Akiyama, H., Mann, D. M. A., & Hasegawa, M. (2013) · Brain · doi:10.1093/brain/awt037 · Cited by 867 · see citing works

Chaperone-mediated autophagy: roles in disease and aging

Cuervo, A. M., & Wong, E. S. P. (2013) · Cell Research · doi:10.1038/cr.2013.153 · Cited by 850 · see citing works

TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity

Decressac, M., Mattsson, B., Weikop, P., Lundblad, M., Jakobsson, J., & Björklund, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305623110 · Cited by 753 · see citing works

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease

Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L., Lachmann, R. H., Li, A., Holton, J., Guerreiro, R., Paudel, R., et al. (2009) · Brain · doi:10.1093/brain/awp044 · Cited by 696 · see citing works

Mammalian Autophagy: How Does It Work?

Bento, C. F., Renna, M., Ghislat, G., Puri, C., Ashkenazi, A., Vicinanza, M., Menzies, F. M., & Rubinsztein, D. C. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014556 · Cited by 692 · see citing works

Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells

Vogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801992200 · Cited by 683 · see citing works

Repression of α-synuclein expression and toxicity by microRNA-7

Junn, E., Lee, K.-W., Jeong, B. S., Chan, T. W., Im, J.-Y., & Mouradian, M. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906277106 · Cited by 634 · see citing works

Dopamine-modified α-synuclein blocks chaperone-mediated autophagy

Martínez‐Vicente, M., Tallóczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J. R., Mosharov, E. V., Hodara, R., Fredenburg, R. A., Wu, D.-C., Follenzi, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32806 · Cited by 633 · see citing works

Structure of the toxic core of α-synuclein from invisible crystals

Rodríguez, J. A., Ivanova, M. I., Sawaya, M. R., Cascio, D., Reyes, F. E., Shi, D., Sangwan, S., Guenther, E. L., Johnson, L. M., Zhang, M., et al. (2015) · Nature · doi:10.1038/nature15368 · Cited by 629 · see citing works

Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease

Filimonenko, M., Stuffers, S., Raiborg, C., Yamamoto, A., Malerød, L., Fisher, E. M. C., Isaacs, A., Brech, A., Stenmark, H., & Simonsen, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200702115 · Cited by 626 · see citing works

Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases

Spencer, B., Potkar, R., Trejo, M., Rockenstein, E., Patrick, C., Gindi, R., Adame, A., Wyss-Coray, T., & Masliah, E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4390-09.2009 · Cited by 595 · see citing works

Interplay of LRRK2 with chaperone-mediated autophagy

Orenstein, S. J., Kuo, S.-H., Tasset, I., Arias, E., Koga, H., Fernandez-Carasa, I., Cortes, E., Honig, L. S., Dauer, W., Consiglio, A., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3350 · Cited by 588 · see citing works

Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies

Kramer, M. L., & Schulz-Schaeffer, W. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4564-06.2007 · Cited by 571 · see citing works

Expression of A53T Mutant But Not Wild-Type α-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death

Stefanis, L., Larsen, K. E., Rideout, H. J., Sulzer, D. L., & Greene, L. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09549.2001 · Cited by 569 · see citing works

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains

Gegg, M. E., Burke, D. G., Heales, S., Cooper, J. A. D., Hardy, J., Wood, N. W., & Schapira, A. H. V. (2012) · Annals of Neurology · doi:10.1002/ana.23614 · Cited by 562 · see citing works

Hsp70 Reduces α-Synuclein Aggregation and Toxicity

Klucken, J., Shin, Y., Masliah, E., Hyman, B. T., & McLean, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400255200 · Cited by 509 · see citing works

Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis

Tanaka, Y. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.919 · Cited by 497 · see citing works

Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153

Doxakis, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086827 · Cited by 485 · see citing works

α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation

Burré, J., Sharma, M., & Südhof, T. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416598111 · Cited by 478 · see citing works

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease

Murphy, K. E., Gysbers, A. M., Abbott, S. K., Tayebi, N., Kim, W. S., Sidransky, E., Cooper, A., Garner, B., & Halliday, G. M. (2014) · Brain · doi:10.1093/brain/awt367 · Cited by 475 · see citing works

Advances in the genetics of Parkinson disease

Trinh, J., & Farrer, M. J. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.132 · Cited by 465 · see citing works

Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons

Chung, C. Y., Khurana, V., Auluck, P. K., Tardiff, D. F., Mazzulli, J. R., Soldner, F., Baru, V., Lou, Y., Freyzon, Y., Cho, S., et al. (2013) · Science · doi:10.1126/science.1245296 · Cited by 442 · see citing works

Phosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy Lesions

Hasegawa, M., Fujiwara, H., Nonaka, T., Wakabayashi, K., Takahashi, H., Lee, V. M.-Y., Trojanowski, J. Q., Mann, D., & Iwatsubo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208046200 · Cited by 428 · see citing works

Aggresomes Formed by α-Synuclein and Synphilin-1 Are Cytoprotective

Tanaka, M., Kim, Y. M., Lee, G., Junn, E., Iwatsubo, T., & Mouradian, M. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310994200 · Cited by 421 · see citing works

Aggregated and Monomeric α-Synuclein Bind to the S6′ Proteasomal Protein and Inhibit Proteasomal Function

Snyder, H. M., Mensah, K., Theisler, C. M., Lee, J., Matouschek, A. T., & Wolozin, B. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208641200 · Cited by 420 · see citing works

Degradation of α-Synuclein by Proteasome

Bennett, M. C., Bishop, J. F., Leng, Y., Chock, P. B., Chase, T. N., & Mouradian, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33855 · Cited by 417 · see citing works

Human Hsp70 Disaggregase Reverses Parkinson’s-Linked α-Synuclein Amyloid Fibrils

Gao, X., Carroni, M., Nussbaum-Krammer, C. I., Mogk, A., Nillegoda, N. B., Szlachcic, A., Guilbride, D. L., Saibil, H. R., Mayer, M. P., & Bukau, B. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.012 · Cited by 404 · see citing works

Formation of Toxic Oligomeric α-Synuclein Species in Living Cells

Outeiro, T. F., Putcha, P., Tetzlaff, J. E., Spoelgen, R., Koker, M., Carvalho, F. L. F., Hyman, B. T., & McLean, P. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001867 · Cited by 400 · see citing works

Prion-like acceleration of a synucleinopathy in a transgenic mouse model

Mougenot, A.-L. J., Nicot, S., Bencsik, A. A., Morignat, E., Verchère, J., Lakhdar, L., Legastelois, S., & Baron, T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.022 · Cited by 375 · see citing works

α-Synucleinopathy phenotypes

McCann, H., Stevens, C. H., Cartwright, H., & Halliday, G. M. (2014) · Parkinsonism &amp; Related Disorders · doi:10.1016/s1353-8020(13)70017-8 · Cited by 364 · see citing works

Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy

Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D. S., & Stefanis, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005515 · Cited by 353 · see citing works

Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy

Wakabayashi, K., Hayashi, S., Kakita, A., Yamada, M., Toyoshima, Y., Yoshimoto, M., & Takahashi, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050918 · Cited by 347 · see citing works

Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6

Olzmann, J. A., Li, L., Chudaev, M. V., Chen, J., Perez, F. A., Palmiter, R. D., & Chin, L. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611128 · Cited by 335 · see citing works

Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s Disease

Osellame, L. D., Rahim, A. A., Hargreaves, I. P., Gegg, M. E., Richard-Loendt, A., Brandner, S., Waddington, S. N., Schapira, A. H. V., & Duchen, M. R. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.014 · Cited by 329 · see citing works

The Co-chaperone Carboxyl Terminus of Hsp70-interacting Protein (CHIP) Mediates α-Synuclein Degradation Decisions between Proteasomal and Lysosomal Pathways

Shin, Y., Klucken, J., Patterson, C., Hyman, B. T., & McLean, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503326200 · Cited by 328 · see citing works

TorsinA and heat shock proteins act as molecular chaperones: suppression of α‐synuclein aggregation

McLean, P. J., Kawamata, H., Shariff, S., Hewett, J. W., Sharma, N., Ueda, K., Breakefield, X. O., & Hyman, B. T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01190.x · Cited by 324 · see citing works

Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies

Schlossmacher, M. G., Frosch, M. P., Gai, W., Medina, M., Sharma, N., Forno, L. S., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61113-3 · Cited by 324 · see citing works

Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration

Goedert, M., Masuda-Suzukake, M., & Falcon, B. (2017) · Brain · doi:10.1093/brain/aww230 · Cited by 323 · see citing works

Spatial sequestration of misfolded proteins by a dynamic chaperone pathway enhances cellular fitness during stress

Escusa-Toret, S., Vonk, W. I. M., & Frydman, J. (2013) · Nature Cell Biology · doi:10.1038/ncb2838 · Cited by 321 · see citing works

Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation

Dettmer, U., Newman, A. J., Soldner, F., Luth, E. S., Kim, N. C., von Saucken, V. E., Sanderson, J. B., Jaenisch, R., Bartels, T., & Selkoe, D. (2015) · Nature Communications · doi:10.1038/ncomms8314 · Cited by 317 · see citing works

Getting into position: the catalytic mechanisms of protein ubiquitylation

Passmore, L. A., & Barford, D. (2004) · Biochemical Journal · doi:10.1042/bj20040198 · Cited by 305 · see citing works

Lewy-body formation is an aggresome-related process: a hypothesis

Olanow, C. W., Perl, D. P., Demartino, G., & McNaught, K. S. P. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00827-0 · Cited by 304 · see citing works

Acid β‐glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α‐synuclein processing

Cullen, V., Sardi, S. P., Ng, J., Xu, Y., Sun, Y., Tomlinson, J. J., Kolodziej, P., Kahn, I. L., Säftig, P., Woulfe, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22400 · Cited by 303 · see citing works

Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, α-Synuclein Accumulation, and Neurotoxicity

Usenovic, M., Tresse, E., Mazzulli, J. R., Taylor, J. P., & Krainc, D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5575-11.2012 · Cited by 291 · see citing works

Pharmacological prevention of Parkinson disease in Drosophila

Auluck, P. K., & Bonini, N. M. (2002) · Nature Medicine · doi:10.1038/nm1102-1185 · Cited by 280 · see citing works

Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease

Lastres‐Becker, I., García‐Yagüe, Á. J., Scannevin, R. H., Casarejos, M. J., Kügler, S., Rábano, A., & Cuadrado, A. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6549 · Cited by 275 · see citing works

Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds

Caruana, M., Högen, T., Levin, J., Hillmer, A. S., Giese, A., & Vassallo, N. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.046 · Cited by 274 · see citing works

Ubiquitin ligase Nedd4 promotes α-synuclein degradation by the endosomal–lysosomal pathway

Tofaris, G. K., Kim, H. T., Hourez, R., Jung, J.-W., Kim, K. P., & Goldberg, A. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109356108 · Cited by 271 · see citing works

Mechanisms and Functions of Spatial Protein Quality Control

Sontag, E. M., Samant, R. S., & Frydman, J. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014616 · Cited by 269 · see citing works

VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for  -Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease

Tang, F.-L., Erion, J. R., Tian, Y., Liu, W., Yin, D.-M., Ye, J., Tang, B., Mei, L., & Xiong, W.-C. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0042-15.2015 · Cited by 269 · see citing works

UCHL1 is a Parkinson's disease susceptibility gene

Maraganore, D. M., Lesnick, T. G., Elbaz, A., Chartier‐Harlin, M., Gasser, T., Krüger, R., Hattori, N., Mellick, G. D., Quattrone, A., Satoh, J., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20017 · Cited by 263 · see citing works

Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease

Gan-Or, Z., Dion, P. A., & Rouleau, G. A. (2015) · Autophagy · doi:10.1080/15548627.2015.1067364 · Cited by 260 · see citing works

Phosphorylation of Synucleins by Members of the Polo-like Kinase Family

Mbefo, M. K., Paleologou, K. E., Boucharaba, A., Oueslati, A., Schell, H., Fournier, M., Olschewski, D., Yin, G., Zweckstetter, M., Masliah, E., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081950 · Cited by 247 · see citing works

TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation

Jinn, S., Drolet, R. E., Cramer, P. E., Wong, H. K., Toolan, D. M., Gretzula, C. A., Voleti, B., Vassileva, G., Disa, J., Tadin‐Strapps, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616332114 · Cited by 244 · see citing works

Differential Scales of Protein Quality Control

Wolff, S., Weissman, J. S., & Dillin, A. G. (2014) · Cell · doi:10.1016/j.cell.2014.03.007 · Cited by 243 · see citing works

Targeting Hsp90/Hsp70-Based Protein Quality Control for Treatment of Adult Onset Neurodegenerative Diseases

Pratt, W. B., Gestwicki, J. E., Osawa, Y., & Lieberman, A. P. (2014) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124332 · Cited by 237 · see citing works

Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease

Magalhães, J., Gegg, M. E., Migdalska‐Richards, A., Doherty, M. K., Whitfield, P. D., & Schapira, A. H. V. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw185 · Cited by 234 · see citing works

Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes

Kong, S. M. Y., Chan, B. K. K., Park, J., Hill, K. J., Aitken, J. B., Cottle, L., Farghaian, H., Cole, A. R., Lay, P. A., Sue, C. M., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu099 · Cited by 233 · see citing works

Cysteine cathepsins are essential in lysosomal degradation of α-synuclein

McGlinchey, R. P., & Lee, J. C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500937112 · Cited by 227 · see citing works

Chaperone‐like activity of synucleins

Souza, J. M., Giasson, B. I., Lee, V. M. ‐., & Ischiropoulos, H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01563-5 · Cited by 221 · see citing works

Unconventional secretion of misfolded proteins promotes adaptation to proteasome dysfunction in mammalian cells

Lee, J., Takahama, S., Zhang, G., Tomarev, S. I., & Ye, Y. (2016) · Nature Cell Biology · doi:10.1038/ncb3372 · Cited by 217 · see citing works

Immunocytochemical Co-localization of the Proteasome in Ubiquitinated Structures in Neurodegenerative Diseases and the Elderly

Ii, K., Ito, H., Tanaka, K., & Hirano, A. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199702000-00002 · Cited by 215 · see citing works

The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease

de Oliveira, R. M., Miranda, H. V., Francelle, L., Pinho, R., Szegő, É. M., Martinho, R., Munari, F., Lázaro, D. F., Moniot, S., Guerreiro, P. S., et al. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2000374 · Cited by 210 · see citing works

α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers

Beyer, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0104-6 · Cited by 208 · see citing works

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease

Alvarez‐Erviti, L., Seow, Y., Schapira, A. H. V., Rodríguez‐Oroz, M., Obeso, J. A., & Cooper, J. A. D. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.73 · Cited by 204 · see citing works

Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo

Oueslati, A., Schneider, B. L., Aebischer, P., & Lashuel, H. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309991110 · Cited by 204 · see citing works

Mechanisms of Suppression of α-Synuclein Neurotoxicity by Geldanamycin in Drosophila

Auluck, P. K., Meulener, M. C., & Bonini, N. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412106200 · Cited by 201 · see citing works

VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease

Miura, E., Hasegawa, T., Konno, M., Suzuki, M., Sugeno, N., Fujikake, N., Geisler, S., Tabuchi, M., Oshima, R., Kikuchi, A., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.014 · Cited by 195 · see citing works

Ubiquitylation of synphilin-1 and α-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease

Liani, E., Eyal, A., Avraham, E., Shemer, R., Szargel, R., Berg, D., Bornemann, A., Rieß, O., Ross, C. A., Rott, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401081101 · Cited by 192 · see citing works

Parkin-mediated K63-linked polyubiquitination: A signal for targeting misfolded proteins to the aggresome-autophagy pathway

Olzmann, J. A., & Chin, L. (2008) · Autophagy · doi:10.4161/auto.5172 · Cited by 182 · see citing works

Astrocyte-Specific Overexpression of Nrf2 Delays Motor Pathology and Synuclein Aggregation throughout the CNS in the Alpha-Synuclein Mutant (A53T) Mouse Model

Gan, L., Vargas, M. R., Johnson, D. A., & Johnson, J. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3049-12.2012 · Cited by 182 · see citing works

Glucose Regulated Protein 78 Diminishes α-Synuclein Neurotoxicity in a Rat Model of Parkinson Disease

Gorbatyuk, M. S., Shabashvili, A. E., Chen, W., Meyers, C., Sullivan, L. F., Salganik, M., Lin, J. H., Lewin, A. S., Muzyczka, N., & Gorbatyuk, O. S. (2012) · Molecular Therapy · doi:10.1038/mt.2012.28 · Cited by 180 · see citing works

Extracellular Chaperones and Proteostasis

Wyatt, A. R., Yerbury, J. J., Ecroyd, H. W., & Wilson, M. R. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072711-163904 · Cited by 180 · see citing works

Brain-Permeable Small-Molecule Inhibitors of Hsp90 Prevent α-Synuclein Oligomer Formation and Rescue α-Synuclein-Induced Toxicity

Putcha, P., Danzer, K. M., Kranich, L. R., Scott, A., Silinski, M. A. R., Mabbett, S. R., Hicks, C. D., Veal, J. M., Steed, P. M., Hyman, B. T., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158436 · Cited by 179 · see citing works

Phenylbutyrate Up-regulates the DJ-1 Protein and Protects Neurons in Cell Culture and in Animal Models of Parkinson Disease

Zhou, W., Bercury, K. K., Cummiskey, J., Luong, N., Lebin, J. A., & Freed, C. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211029 · Cited by 178 · see citing works

Small Heat Shock Proteins Potentiate Amyloid Dissolution by Protein Disaggregases from Yeast and Humans

Duennwald, M. L., Echeverria, A., & Shorter, J. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001346 · Cited by 178 · see citing works

Proteomic identification of novel proteins associated with Lewy bodies

Xia, Q. (2008) · Frontiers in bioscience · doi:10.2741/2973 · Cited by 176 · see citing works

CHIP Targets Toxic α-Synuclein Oligomers for Degradation

Tetzlaff, J. E., Putcha, P., Outeiro, T. F., Ivanov, A., Berezovska, O., Hyman, B. T., & McLean, P. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802283200 · Cited by 175 · see citing works

Monoubiquitylation of α-Synuclein by Seven in Absentia Homolog (SIAH) Promotes Its Aggregation in Dopaminergic Cells

Rott, R., Szargel, R., Haskin, J., Shani, V., Shainskaya, A., Manov, I., Liani, E., Avraham, E., & Engelender, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704809200 · Cited by 174 · see citing works

α-Synuclein fate is determined by USP9X-regulated monoubiquitination

Rott, R., Szargel, R., Haskin, J., Bandopadhyay, R., Lees, A. J., Shani, V., & Engelender, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105725108 · Cited by 174 · see citing works

Analysis of α-Synuclein-associated Proteins by Quantitative Proteomics

Zhou, Y. F., Gu, G., Goodlett, D. R., Zhang, T., Pan, C., Montine, T. J., Montine, K. S., Aebersold, R. H., & Zhang, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405456200 · Cited by 173 · see citing works

Proteasome inhibitors

Teicher, B. A., & Tomaszewski, J. E. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.04.008 · Cited by 172 · see citing works

Increased striatal dopamine release and hyperdopaminergic‐like behaviour in mice lacking both alpha‐synuclein and gamma‐synuclein

Senior, S. L., Ninkina, N. N., Deacon, R. M. J., Bannerman, D. M., Buchman, V. L., Cragg, S. J., & Wade‐Martins, R. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06055.x · Cited by 164 · see citing works

Lysosomal‐associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease

Murphy, K. E., Gysbers, A. M., Abbott, S. K., Spiro, A. S., Furuta, A., Cooper, A. A., Garner, B., Kabuta, T., & Halliday, G. M. (2015) · Movement Disorders · doi:10.1002/mds.26141 · Cited by 163 · see citing works

MicroRNAs in Parkinson's disease

Harraz, M. M., Dawson, T. M., & Dawson, V. L. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.01.005 · Cited by 160 · see citing works

Zn2+ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation

Tsunemi, T., & Krainc, D. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt572 · Cited by 159 · see citing works

Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models

Sánchez-Martínez, Á., Beavan, M. S., Gegg, M. E., Chau, K., Whitworth, A. J., & Schapira, A. H. V. (2016) · Scientific Reports · doi:10.1038/srep31380 · Cited by 158 · see citing works

Spermidine protects against α-synuclein neurotoxicity

Büttner, S., Broeskamp, F., Sommer, C., Markaki, M., Habernig, L., Alavian‐Ghavanini, A., Carmona‐Gutiérrez, D., Eisenberg, T., Michael, E., Kroemer, G., et al. (2014) · Cell Cycle · doi:10.4161/15384101.2014.973309 · Cited by 157 · see citing works

Synthetic polyubiquitinated α-Synuclein reveals important insights into the roles of the ubiquitin chain in regulating its pathophysiology

Haj‐Yahya, M., Fauvet, B., Herman-Bachinsky, Y., Hejjaoui, M., Bavikar, S. N., Karthikeyan, S. V., Ciechanover, A. J., Lashuel, H. A., & Brik, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315654110 · Cited by 154 · see citing works

Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease

Tenreiro, S., Reimão-Pinto, M. M., Antas, P., Rino, J., Wawrzycka, D., Macedo, D., Rosado-Ramos, R., Amen, T., Waiss, M., Magalhães, F., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004302 · Cited by 147 · see citing works

Evidence for Intramolecular Antiparallel Beta-Sheet Structure in Alpha-Synuclein Fibrils from a Combination of Two-Dimensional Infrared Spectroscopy and Atomic Force Microscopy

Roeters, S. J., Iyer, A., Pletikapić, G., Kogan, V., Subramaniam, V., & Woutersen, S. (2017) · Scientific Reports · doi:10.1038/srep41051 · Cited by 146 · see citing works

Genetic and Chemical Activation of TFEB Mediates Clearance of Aggregated α-Synuclein

Kilpatrick, K., Zeng, Y., Hancock, T., & Segatori, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120819 · Cited by 143 · see citing works

The Mitochondrial Chaperone Protein TRAP1 Mitigates α-Synuclein Toxicity

Butler, E. K., Voigt, A., Lutz, A. K., Toegel, J. P., Gerhardt, E., Karsten, P., Falkenburger, B. H., Reinartz, A., Winklhofer, K. F., & Schulz, J. B. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002488 · Cited by 142 · see citing works

GBA deficiency promotes SNCA/α-synuclein accumulation through autophagic inhibition by inactivated PPP2A

Du, T., Wang, L., Duan, C., Lu, L., Zhang, J., Gao, G., Qiu, X., Wang, X., & Yang, H. (2015) · Autophagy · doi:10.1080/15548627.2015.1086055 · Cited by 129 · see citing works

Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease

Alexopoulou, Z., Lang, J., Perrett, R. M., Elschami, M., Hurry, M. E. D., Kim, H. T., Mazaraki, D., Szabó, Á., Kessler, B. M., Goldberg, A. L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523597113 · Cited by 127 · see citing works

Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats

Xilouri, M., Brekk, O. R., Polissidis, A., Chrysanthou‐Piterou, M., Kloukina, I., & Stefanis, L. (2016) · Autophagy · doi:10.1080/15548627.2016.1214777 · Cited by 126 · see citing works

Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies

Peterson, L. F., Sun, H., Liu, Y., Potu, H., Kandarpa, M., Ermann, M., Courtney, S. M., Young, M. A., Showalter, H. D., Sun, D., et al. (2015) · Blood · doi:10.1182/blood-2014-10-605584 · Cited by 123 · see citing works

LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance

Rothaug, M., Zunke, F., Mazzulli, J. R., Schweizer, M., Altmeppen, H. C., Lüllmann‐Rauch, R., Kallemeijn, W. W., Gaspar, P., Aerts, J. M. F. G., Glatzel, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405700111 · Cited by 122 · see citing works

Defending the mitochondria: The pathways of mitophagy and mitochondrial-derived vesicles

Roberts, R. F., Tang, M. Y. H., Fon, E. A., & Durcan, T. M. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.020 · Cited by 120 · see citing works

Nrf2 mitigates LRRK2- and α-synuclein–induced neurodegeneration by modulating proteostasis

Skibinski, G., Hwang, V., Ando, D. M., Daub, A. C., Lee, A. K., Ravisankar, A., Modan, S., Finucane, M. M., Shaby, B. A., & Finkbeiner, S. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522872114 · Cited by 116 · see citing works

α-Synuclein Can Inhibit SNARE-Mediated Vesicle Fusion through Direct Interactions with Lipid Bilayers

DeWitt, D. C., & Rhoades, E. R. (2013) · Biochemistry · doi:10.1021/bi4002369 · Cited by 93 · see citing works

Proteasome dysfunction in aged human α-synuclein transgenic mice

Chen, L., Thiruchelvam, M. J., Madura, K., & Richfield, E. K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.004 · Cited by 88 · see citing works

Molecular Chaperones in Parkinson's Disease – Present and Future

Ebrahimi‐Fakhari, D., Wahlster, L., & McLean, P. J. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11044 · Cited by 82 · see citing works

S-nitrosylation of UCHL1 induces its structural instability and promotes α-synuclein aggregation

Kumar, R., Jangir, D. K., Verma, G., Shekhar, S., Hanpude, P., Kumar, S., Kumari, R., Singh, N., Bhavesh, N. S., Jana, N. R., et al. (2017) · Scientific Reports · doi:10.1038/srep44558 · Cited by 82 · see citing works

Parkinson Disease-linked Vps35 R524W Mutation Impairs the Endosomal Association of Retromer and Induces α-Synuclein Aggregation

Follett, J., Bugarc̀ić, A., Yang, Z., Ariotti, N., Norwood, S. J., Collins, B. M., Parton, R. G., & Teasdale, R. D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.703157 · Cited by 81 · see citing works

Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson’s Disease

Sala, G., Marinig, D., Arosio, A., & Ferrarese, C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00157 · Cited by 81 · see citing works

Protein Quality Control in Health and DiseasePreprint

Dubnikov, T., Ben‐Gedalya, T., & Cohen, E. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023523 · Cited by 79 · see citing works

Interplay between Sumoylation and Phosphorylation for Protection against α-Synuclein Inclusions

Shahpasandzadeh, H., Popova, B., Kleinknecht, A., Fraser, P. E., Outeiro, T. F., & Braus, G. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559237 · Cited by 79 · see citing works

Defective quality control mechanisms and accumulation of damaged mitochondria link Gaucher and Parkinson diseases

Osellame, L. D., & Duchen, M. R. (2013) · Autophagy · doi:10.4161/auto.25878 · Cited by 79 · see citing works

Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease

Ren, R., Shi, C., Cao, J., Sun, Y. X., Zhao, X. S., Guo, Y., Wang, C., Lei, H., Jiang, H., Ablat, N., et al. (2016) · Scientific Reports · doi:10.1038/srep22135 · Cited by 77 · see citing works

Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative

Gautam, S., Karmakar, S., Batra, R., Sharma, P. V., Pradhan, P. C., Singh, J., Kundu, B., & Chowdhury, P. K. (2017) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2017.02.014 · Cited by 74 · see citing works

Engineering enhanced protein disaggregases for neurodegenerative disease

Jackrel, M. E., & Shorter, J. (2015) · Prion · doi:10.1080/19336896.2015.1020277 · Cited by 72 · see citing works

Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions

Miki, Y., Mori, F., Tanji, K., Kakita, A., Takahashi, H., & Wakabayashi, K. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2011.01200.x · Cited by 72 · see citing works

MicroRNAs in Parkinson’s disease

Singh, A., & Sen, D. (2017) · Experimental Brain Research · doi:10.1007/s00221-017-4989-1 · Cited by 72 · see citing works

Differential Effects of UCHL1 Modulation on Alpha-Synuclein in PD-Like Models of Alpha-Synucleinopathy

Cartier, A. E., Ubhi, K. K., Spencer, B. J., Vázquez‐Roque, R. A., Kosberg, K. A., Fourgeaud, L., Kanayson, P., Patrick, C., Rockenstein, E. M., Patrick, G. N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034713 · Cited by 70 · see citing works

A Human Neural Crest Stem Cell-Derived Dopaminergic Neuronal Model Recapitulates Biochemical Abnormalities in GBA1 Mutation Carriers

Yang, S., Beavan, M. S., Chau, K., Taanman, J., & Schapira, A. H. V. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.01.011 · Cited by 68 · see citing works

Acupuncture promotes mTOR-independent autophagic clearance of aggregation-prone proteins in mouse brain

Tian, T., Sun, Y., Wu, H., Pei, J., Zhang, J., Zhang, Y., Wang, L., Li, B., Wang, L., Shi, J., et al. (2016) · Scientific Reports · doi:10.1038/srep19714 · Cited by 64 · see citing works

The loss of glucose-regulated protein 78 (GRP78) during normal aging or from siRNA knockdown augments human alpha-synuclein (α-syn) toxicity to rat nigral neurons

Salganik, M., Sergeyev, V., Shinde, V. M., Meyers, C., Gorbatyuk, M. S., Lin, J. H., Zolotukhin, S., & Gorbatyuk, O. S. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.018 · Cited by 61 · see citing works

The ubiquitin ligase E6‐AP promotes degradation of α‐synuclein

Mulherkar, S. A., Sharma, J., & Jana, N. R. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06293.x · Cited by 60 · see citing works

Alpha-Synuclein and Chaperones in Dementia With Lewy Bodies

Cantuti‐Castelvetri, I., Klucken, J., Ingelsson, M., Ramasamy, K., McLean, P. J., Frosch, M. P., Hyman, B. T., & Standaert, D. G. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000190063.90440.69 · Cited by 58 · see citing works

Protective Role of DNJ-27/ERdj5 in Caenorhabditis elegans Models of Human Neurodegenerative Diseases

Muñoz-Lobato, F., Rodríguez‐Palero, M. J., Naranjo-Galindo, F. J., Shephard, F., Gaffney, C. J., Szewczyk, N. J., Hamamichi, S., Caldwell, K. A., Caldwell, G. A., Link, C. D., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5051 · Cited by 56 · see citing works

The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews

Dagan, E., Schlesinger, I., Ayoub, M., Mory, A., Nassar, M., Kurolap, A., Peretz-Aharon, J., & Gershoni‐Baruch, R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.06.016 · Cited by 55 · see citing works

Engineering therapeutic protein disaggregases

Shorter, J. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-10-0693 · Cited by 52 · see citing works

Chaperone-like activities of α-synuclein: α-Synuclein assists enzyme activities of esterases

Ahn, M., Kim, S., Kang, M., Ryu, Y., & Kim, T. D. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.213 · Cited by 50 · see citing works

LAMP2A as a therapeutic target in Parkinson disease

Xilouri, M., Brekk, O. R., Kirik, D., & Stefanis, L. (2013) · Autophagy · doi:10.4161/auto.26451 · Cited by 49 · see citing works

New Roles of Glycosaminoglycans in α-Synuclein Aggregation in a Cellular Model of Parkinson Disease

Lehri-Boufala, S., Ouidja, M. O., Barbier-Chassefière, V., Hénault, E., Raisman‐Vozari, R., Garrigue‐Antar, L., Papy-García, D., & Morin, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116641 · Cited by 46 · see citing works

Histone deacetylase 6 regulates cytotoxic α-synuclein accumulation through induction of the heat shock response

Du, Y., Wang, F., Zou, J., Le, W., Dong, Q., Wang, Z., Shen, F., Yu, L., & Li, Y. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.029 · Cited by 45 · see citing works

The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity

Jarvela, T. S., Lam, H. A., Helwig, M., Lorenzen, N., Otzen, D. E., McLean, P. J., Maidment, N. T., & Lindberg, I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601091113 · Cited by 45 · see citing works

Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated α-Synuclein-selective Autophagic Degradation

Dahmene, M., Bérard, M., & Oueslati, A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.759373 · Cited by 34 · see citing works

The ubiquitin proteasome system as a potential therapeutic target for treatment of neurodegenerative diseases.

Opattová, A., Cente, M., Novak, M., & Filipčík, P. (2015) · PubMed · doi:10.4149/gpb_2015024 · Cited by 32 · see citing works

Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson’s disease

Sharma, S., & Priya, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2340-9 · Cited by 31 · see citing works

Heat shock proteins reduce α‐synuclein aggregation induced by MPP+ in SK‐N‐SH cells

Fan, G., Zhou, H., Yang, H., & Chen, S. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.057 · Cited by 30 · see citing works

Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins

Braun, R. J. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00008 · Cited by 25 · see citing works

Heat shock proteins reduce alpha-synuclein aggregation induced by MPP＋ in SK-N-SH cells.

Fan, J., Gh, Zhou, Hy, Yang, Chert, & Sd (2006) · 中国生物学文摘 · Cited by 22 · see citing works

Direct Visualization of CHIP-Mediated Degradation of Alpha-Synuclein In Vivo: Implications for PD Therapeutics

Dimant, H., Zhu, L., Kibuuka, L. N., Fan, Z., Hyman, B. T., & McLean, P. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092098 · Cited by 21 · see citing works

Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment

Kahan, B. D. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.579898 · Cited by 19 · see citing works

Impairment of redox state and dopamine level induced by α-synuclein aggregation and the prevention effect of hsp70

Yu, F., Xu, H., Zhuo, M., Sun, L., Dong, A., & Liu, X. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.148 · Cited by 19 · see citing works

Rare ER protein misfolding-mistrafficking disorders: Therapeutic developments

Hegde, R. N., Subramanian, A., Pothukuchi, P., Parashuraman, S., & Luini, A. (2017) · Tissue and Cell · doi:10.1016/j.tice.2017.02.001 · Cited by 11 · see citing works

Phosphorylation of α-synuclein is crucial in compensating for proteasomal dysfunction

Choi, H. S., Liew, H., Jang, A., Kim, Y., Lashuel, H. A., & Suh, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.159 · Cited by 10 · see citing works

Impairment of redox state and dopamine level induced by alpha-synuclein aggregation and the prevention effect of hsp70

Yu, Xü, Zhuo, Sun, Dong, & Liu (2006) · 中国生物学文摘 · Cited by 10 · see citing works

Autophagy activation promotes clearance of α-synuclein inclusions in fibril-seeded human neural cells

Gao, J., Perera, G., Bhadbhade, M., Halliday, G. M., & Dzamko, N. L. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008733 · Cited by 116 · see citing works

Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson’s disease

Khan, M. R., Yin, X., Kang, S.-U., Mitra, J., Wang, H., Ryu, T., Brahmachari, S., Karuppagounder, S. S., Kimura, Y., Jhaldiyal, A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add0499 · Cited by 64 · see citing works

Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era

Li, D., Mastaglia, F. L., Fletcher, S., & Wilton, S. D. (2020) · Medicinal Research Reviews · doi:10.1002/med.21718 · Cited by 57 · see citing works

Brain aging: A Ianus‐faced player between health and neurodegeneration

Vanni, S., Baldeschi, A. C., Zattoni, M., & Legname, G. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24379 · Cited by 49 · see citing works

Distinct alpha‐Synuclein species induced by seeding are selectively cleared by the Lysosome or the Proteasome in neuronally differentiated SH‐SY5Y cells

Pantazopoulou, M., Brembati, V., Kanellidi, A., Bousset, L., Melki, R., & Stefanis, L. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15174 · Cited by 49 · see citing works

Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions

Bayati, A., & McPherson, P. S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107742 · Cited by 46 · see citing works

SUMOylation, aging and autophagy in neurodegeneration

Vijayakumaran, S., & Pountney, D. L. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.02.015 · Cited by 32 · see citing works

Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans

Chen, K. S., Menezes, K. S., Rodgers, J. B., O’Hara, D. M., Tran, N. A., Fujisawa, K., Ishikura, S., Khodaei, S., Chau, H., Cranston, A., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00497-6 · Cited by 30 · see citing works

MicroRNAs to differentiate Parkinsonian disorders: Advances in biomarkers and therapeutics

Ramaswamy, P., Christopher, R., Pal, P. K., & Yadav, R. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.08.032 · Cited by 25 · see citing works

Dementia associated with disorders of the basal ganglia

Vitanova, K. S., Stringer, K. M., Benítez, D. P., Brenton, J., & Cummings, D. M. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24508 · Cited by 23 · see citing works

Formation of Heterotypic Amyloids: α‐Synuclein in Co‐Aggregation

Bhasne, K., & Mukhopadhyay, S. (2018) · PROTEOMICS · doi:10.1002/pmic.201800059 · Cited by 17 · see citing works

Robust Sequence Determinants of α-Synuclein Toxicity in Yeast Implicate Membrane Binding

Newberry, R. W., Arhar, T., Costello, J. M., Hartoularos, G. C., Maxwell, A. M., Naing, Z. Z. C., Pittman, M., Reddy, N. R., Schwarz, D. M. C., Wassarman, D. R., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00339 · Cited by 13 · see citing works

T-Type Ca2+ Enhancer SAK3 Activates CaMKII and Proteasome Activities in Lewy Body Dementia Mice Model

Xu, J., Kawahata, K., Izumi, H., & Fukunaga, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126185 · Cited by 12 · see citing works

Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson’s Disease “Off” Episodes

Berger, A. A., Winnick, A. A., Izygon, J. J., Jacob, B. M., Kaye, J. S., Kaye, R. J., Neuchat, E. E., Kaye, A. M., Alpaugh, E. S., Cornett, E. M., et al. (2022) · Health Psychology Research · doi:10.52965/001c.36074 · Cited by 8 · see citing works

Significant Role of Long Non-coding RNAs in Parkinson’s Disease

Chen, N., Wen-Wen, C., Li, W., Zhou, A.-J., & Wang, T. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220922110551 · Cited by 3 · see citing works

STIP1/HOP promotes the formation of cytotoxic α-synuclein oligomers

Rutledge, B. S., Wilson, C. J., Lau, R. M., Jurado-Coronel, J. C., del Cid‐Pellitero, E., Karttunen, M., Durcan, T. M., Fon, E. A., Prado, M. A. M., Legleiter, J. A., et al. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00030-3 · Cited by 2 · see citing works

Alteration in the Expression of Parkinson’s-Related Genes in Rat Hippocampus by Exercise and Morphine Treatments

Sasan, H., Hashemabadi, M., Amandadi, M., & Ravan, H. (2020) · Russian Journal of Genetics · doi:10.1134/s1022795420040122 · Cited by 2 · see citing works

Enhanced mTORC1 signaling and Protein Synthesis in Parkinson’s Disease Pathogenesis Disease Pathogenesis

Khan, M. R., Yin, X., Kang, S.-U., Mitra, J., Wang, H., Brahmachari, S., Karuppagounder, S. S., Kimura, Y., Jhaldiyal, A., Kim, H. H., et al. (2022) · doi:10.1101/2022.10.03.510455

Future Perspectives and Challenges in the Field of Proteostasis and Neurodegenerative Disorders

Chaudhary, S., Shrivastava, V., Kumar, M., Agrawal, E., Singh, N., & Tomar, R. S. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_18

Astrocytic Cathepsin D truncates α-synuclein and promotes Lewy neurite-like aggregation in neuronsPreprint

Hanafusa, H., Ohashi, K., Shojima, H., Hisamoto, N., Kameyama, T., Miyata, M., Mizutani, K., Takai, Y., & Matsumoto, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.03.680233

Protein Quality Control Pathways at the Crossroad of Synucleinopathies

de Mattos, E. P., Wentink, A. S., Nussbaum-Krammer, C. I., Hansen, C., Bergink, S., Melki, R., & Kampinga, H. H. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191790 · Cited by 45 · see citing works

In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons

Fouka, M., Mavroeidi, P., Tsaka, G., & Xilouri, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559791 · Cited by 26 · see citing works

Targeting α-Synuclein: Current Strategies and Emerging Therapies for Synucleinopathies

Bala, V. C., Singh, M., Kumar, A., Tiwari, S. K., Gupta, A. K., Chawla, R. L., & Kumar, S. (2026) · Protein and Peptide Letters · doi:10.2174/0109298665429866260217115717 · Cited by 1 · see citing works

Reprogramming the proteostasis network to prevent the accumulation of alpha-synuclein aggregates

Kilpatrick, K. (2014) · Rice Research Repository (Rice University)

Multifaceted performances of α-synuclein in health and neurological diseases

Wang, M., Xu, Y., Wang, S., Liang, J., Cui, X., Zhang, C., Yang, J., Sun, L., & Jin, M. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.02.031 · Cited by 4 · see citing works